STOCK TITAN

Guardant Health (GH) Co-CEO reports RSU vesting and tax share withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardant Health, Inc. Co-Chief Executive Officer AmirAli Talasaz reported routine equity compensation activity involving restricted stock units. On June 30 and July 1, 2026, a total of 36,529 restricted stock units converted into common stock through derivative exercises, reflecting scheduled vesting.

Across the same dates, 18,514 common shares were withheld and retained by the company at prices of $150.03 and $170.77 per share to cover tax liabilities associated with these vesting events. The transactions occurred through the Talasaz and Eskandari 2017 Family Trust and do not involve any open-market purchases or sales.

Positive

  • None.

Negative

  • None.

Insights

Form 4 shows RSU vesting with tax withholding, not open-market trading.

Co-CEO AmirAli Talasaz reported derivative exercises where restricted stock units converted into common stock. The filing aggregates 36,529 RSUs exercised into common shares and 18,514 shares withheld for taxes, based on the transaction summary.

The footnotes explain the company retained shares to satisfy tax withholding obligations upon vesting, with amounts not exceeding the tax liability. Because there are no open-market buys or sells, this is standard compensation-related activity and a weak informational signal about insider sentiment.

Insider Talasaz AmirAli
Role Co-Chief Executive Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 23,997 $0.00 --
Exercise Restricted Stock Units 9,715 $0.00 --
Exercise Common Stock 23,997 $0.00 --
Exercise Common Stock 9,715 $0.00 --
Tax Withholding Common Stock 17,086 $170.77 $2.92M
Exercise Restricted Stock Units 2,817 $0.00 --
Exercise Common Stock 2,817 $0.00 --
Tax Withholding Common Stock 1,428 $150.03 $214K
Holdings After Transaction: Restricted Stock Units — 47,995 shares (Direct, null); Common Stock — 1,906,722 shares (Indirect, Shares held by Talasaz and Eskandari 2017 Family Trust)
Footnotes (1)
  1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
RSUs exercised 36,529 shares Total derivative exercise shares from transaction summary
Tax withholding shares 18,514 shares Total tax-withholding dispositions from transaction summary
Tax withholding price 1 $150.03/share 1,428 shares withheld on June 30, 2026
Tax withholding price 2 $170.77/share 17,086 shares withheld on July 1, 2026
July 1 RSU exercise 1 9,715 shares Restricted Stock Units converting to common stock
July 1 RSU exercise 2 23,997 shares Restricted Stock Units converting to common stock
June 30 RSU exercise 2,817 shares Restricted Stock Units converting to common stock
Restricted Stock Units financial
"This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"retained by the Company in order to meet the tax withholding obligations of the award-holder"
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
restricted stock unit award financial
"This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Talasaz AmirAli

(Last)(First)(Middle)
3100 HANOVER STREET

(Street)
PALO ALTO CALIFORNIA 94304

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Co-Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026M2,817A$01,884,153IShares held by Talasaz and Eskandari 2017 Family Trust
Common Stock06/30/2026F1,428(1)D$150.031,882,725IShares held by Talasaz and Eskandari 2017 Family Trust
Common Stock07/01/2026M23,997A$01,906,722IShares held by Talasaz and Eskandari 2017 Family Trust
Common Stock07/01/2026M9,715A$01,916,437IShares held by Talasaz and Eskandari 2017 Family Trust
Common Stock07/01/2026F17,086(1)D$170.771,899,351IShares held by Talasaz and Eskandari 2017 Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$006/30/2026M2,817 (2) (3)Common Stock2,817$05,634D
Restricted Stock Units$007/01/2026M23,997 (4) (3)Common Stock23,997$047,995D
Restricted Stock Units$007/01/2026M9,715 (5) (3)Common Stock9,715$058,296D
Explanation of Responses:
1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
2. This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026.
3. Not applicable for Restricted Stock Units.
4. This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
5. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Remarks:
/s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Guardant Health (GH) report for AmirAli Talasaz?

Guardant Health reported RSU vesting transactions for Co-CEO AmirAli Talasaz. On June 30 and July 1, 2026, restricted stock units converted into common stock, and some shares were retained by the company to cover related tax withholding obligations, as is typical for equity compensation awards.

Were any Guardant Health (GH) shares bought or sold on the open market in this Form 4?

No open-market purchases or sales were reported in this Form 4. The transactions consist of restricted stock units converting into common stock and shares withheld by the company to satisfy tax obligations, which are compensation mechanics rather than discretionary market trades by the insider.

How many restricted stock units vested for Guardant Health (GH) Co-CEO AmirAli Talasaz?

A total of 36,529 restricted stock units converted into common stock. The transaction summary shows 36,529 shares linked to derivative exercises, reflecting scheduled vesting from multiple RSU awards with quarterly vesting schedules described in the accompanying footnotes.

How many Guardant Health (GH) shares were withheld for taxes in these transactions?

A total of 18,514 shares were withheld for tax obligations. The transaction summary identifies 18,514 shares as tax-withholding dispositions, with the footnotes clarifying that the company retained shares solely to meet the award-holder’s tax liability upon RSU vesting.

At what share prices did Guardant Health (GH) withhold stock for taxes?

Shares were withheld at prices of $150.03 and $170.77 per share. On June 30, 2026, 1,428 shares were withheld at $150.03, and on July 1, 2026, 17,086 shares were withheld at $170.77, both to cover tax liabilities tied to restricted stock unit vesting.

How are the Guardant Health (GH) shares held for AmirAli Talasaz structured?

Many reported common shares are held indirectly through a family trust. Several common stock entries note ownership as “Shares held by Talasaz and Eskandari 2017 Family Trust,” indicating indirect holdings, while the restricted stock unit awards themselves are reported as directly owned derivative securities.